Using peptides primarily for psychological well-being without biomarker feedback can lead to dose escalation and increased risk. — Whalespan
Using peptides primarily for psychological well-being without biomarker feedback can lead to dose escalation and increased risk.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“This creates a dangerous situation where powerful compounds are being used less for biomarker improvement and more for psychological wellbeing. Without biomarker feedback, dose escalation is driven by subjective feelings which creates increased risk of doses with no clinical precedent.”